Pediatric Hair Cosmetics: Physiology, Safety, and Product Considerations

Hector Cantu-Maltos1, Lorena Bojalil1, Luz Orozco-Covarrubias1

  • 1Dermatology Department, Instituto Nacional de Pediatría, Mexico City, Mexico.

Insights

Pediatric hair care needs gentle, evidence-based products due to unique child physiology. Current regulations lack age-specific guidelines, emphasizing the need for child-focused research and safer formulations.

Area of Science:

  • Pediatric Dermatology
  • Cosmetic Science

Background:

  • Children's hair and scalp have distinct physiological and structural properties compared to adults.
  • These differences necessitate specialized, evidence-based approaches to pediatric hair care.

Purpose of the Study:

  • To review current knowledge on pediatric hair physiology and the use of hair products.
  • To analyze cosmetic product categories, ingredients, and safety considerations for children.

Main Methods:

  • Narrative review of scientific literature on pediatric hair physiology and cosmetic science.
  • Analysis of hair product classifications, mechanisms of action, and ingredient effects.
  • Examination of safety aspects including irritation, sensitization, and endocrine disruption.

Main Results:

  • Pediatric hair physiology is characterized by lower sebum production and age-dependent changes in hair density.
  • Hair care product interaction with hair and scalp varies significantly with age and hair type.
  • Current cosmetic regulations lack age-specific policies, and long-term safety data for children is limited.

Conclusions:

  • Pediatric hair care should prioritize gentle formulations with controlled pH and minimal irritant potential.
  • There is a critical need for clearer regulations and more child-focused research in pediatric cosmetic safety.
  • Hair care practices for children should be need- and function-oriented, not solely routine-driven.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Accessory Structures of the Skin: Hair Growth and Types01:20

Accessory Structures of the Skin: Hair Growth and Types

Hair growth begins with the production of keratinocytes by the basal cells of the hair bulb. As new cells are deposited at the hair bulb, the hair shaft is pushed through the follicle toward the surface. Keratinization is completed as the cells are pushed to the skin surface to form the shaft of hair that is externally visible. The external hair is completely dead and composed entirely of keratin. Hair can be cut or shaven without damaging the hair structure because the cut is superficial. Most...